Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Pa
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 212.79 +0.82 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $211.97 | 52 Week High | $160.00 | |||
| Open | $211.38 | 52 Week Low | $95.80 | |||
| Day High | $214.00 | P/E | 39.55 | |||
| Day Low | $210.43 | EPS | $5.38 | |||
| Volume | 75,647 | |||||
